Ikarian Capital »

Pepgen shares owned by Ikarian Capital

Quarter-by-quarter ownership of Pepgen (PEPG) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Pepgen

Tip: Access up to 7 years of quarterly data

All positions including Pepgen held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pepgen by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.5M 536k 4.62
2025-06-30 $167k 150k 1.11
2025-03-31 $211k 150k 1.41

More positions owned by Ikarian Capital

United Therapeutics Corporation Put Option (UTHR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Genmab A/s Sponsored Ads (GMAB)
Bristol Myers Squibb Put Option (BMY)
Abivax Sa Sponsored Ads (ABVX)
Uniqure Nv Call Call Option
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Ionis Pharmaceuticals (IONS)
Cidara Therapeutics Com New (CDTX)
Scholar Rock Hldg Corp Put Option (SRRK)
Rapt Therapeutics Com New (RAPT)
Maze Therapeatics (MAZE)
Soleno Therapeutics (SLNO)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Pepgen

RA Capital Management
Viking Global Investors
Commodore Capital
Vivo Capital
Point72 Asset Management
BVF
Laurion Capital Management
Vanguard Group
Henderson Group
Rtw Investments
Adage Capital Partners GP
Balyasny Asset Management
Woodline Partners
Deep Track Capital
TCG Crossover Management

View all funds holding Pepgen